Revises telehealth and telemedicine requirements concerning adult prescription of certain Schedule II drugs for treatment of attention-deficit/hyperactivity disorder.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 2 Sponsors

No summary has been published for this bill. The full text is on the Bill text tab.

Chamber: Senate
Introduced: May 11, 2026
Last action: Jun 11, 2026 — Combined with S4194 (SCS)
Session: 222
Momentum: 27 · Low

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base In Committee — base rate 4%, measured from NJ's completed sessions
Momentum -5 27/100 from the pace of recorded action
Time since last action -16 121 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.